The Board granted the appeal, setting the proper effective date for the reduction in the rating for prostate cancer residuals from 100 percent to 60 percent as February 28, 2025.
The deciding factor: The decision was based on the correct application of 38 C.F.R. § 3.500 (r) which sets the effective date as the last day of the month following 60 days after notice to payee.
- Claimed conditions
- prostate cancer residuals
- How they argued it
- Not specified
- Exposure basis
- None
- Rating assigned
- 60%
- Decision date
- June 25, 2025
- Citation
- A25055022
What this means for you
A grant means the Board agreed the veteran was entitled to the benefit. Decisions like this show the kind of evidence and arguments that tend to succeed for claims like it.
What you can do next
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Partly granted
The Board granted a 40 percent evaluation for prostate cancer residuals from January 29, 2014 to August 12, 2021.
- Denied
The Board denied the Veteran's claim for a total disability rating based on individual unemployability (TDIU) due to his service-connected disabilities, including prostate cancer residuals, hearing loss, tinnitus, and erectile dysfunction.
- Dismissed
The appeal of a proposal to reduce the rating for service-connected prostate cancer residuals from 100 percent to 40 percent is dismissed as it was not a final decision.
- Granted
The Veteran's prostate cancer residuals are granted a 60 percent rating from July 7, 2023.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.